American Society for Radiation Oncology (ASTRO) and American College of Radiology (ACR) Practice Guideline for the Transperineal Permanent Brachytherapy of Prostate Cancer

详细信息    查看全文

• 作者：Seth A. Rosenthal M.D.^* ; ^{rosenthals@radiological.com} ; Nathan H.J. Bittner M.D. ; M.S.^† ; ; David C. Beyer M.D.^‡ ; ; D. Jeffrey Demanes M.D.^§ ; ; Brian J. Goldsmith M.D.^* ; Eric M. Horwitz M.D.^¶ ; ; Geoffrey S. Ibbott Ph.D. ; W. Robert Lee M.D.^# ; Subir Nag M.D.^** ; W. Warren Suh M.D.^† ; † ; ; Louis Potters M.D.^‡ ; ‡ ;
• 刊名：International Journal of Radiation Oncology*Biology*Physics
• 出版年：2011
• 出版时间：1 February 2011
• 年：2011
• 卷：79
• 期：2
• 页码：335-341
• 全文大小：118 K

文摘

Transperineal permanent prostate brachytherapy is a safe and efficacious treatment option for patients with organ-confined prostate cancer. Careful adherence to established brachytherapy standards has been shown to improve the likelihood of procedural success and reduce the incidence of treatment-related morbidity. A collaborative effort of the American College of Radiology (ACR) and American Society for Therapeutic Radiation Oncology (ASTRO) has produced a practice guideline for permanent prostate brachytherapy.

The guideline defines the qualifications and responsibilities of all the involved personnel, including the radiation oncologist, physicist and dosimetrist. Factors with respect to patient selection and appropriate use of supplemental treatment modalities such as external beam radiation and androgen suppression therapy are discussed. Logistics with respect to the brachtherapy implant procedure, the importance of dosimetric parameters, and attention to radiation safety procedures and documentation are presented. Adherence to these practice guidelines can be part of ensuring quality and safety in a successful prostate brachytherapy program.